ArticleBMC public health2026
The impact of the COVID-19 pandemic on healthy volunteer motivations: a mixed-methods study of participants in plague vaccine trials in the UK and Uganda.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundThe COVID-19 pandemic led to unprecedented interest and participation in vaccine trials globally, and a concurrent increase in vaccine hesitancy. Whether this impacted recruitment of healthy volunteers to subsequent non-COVID vaccine trials is not well studied. We explored the impact of the COVID-19 pandemic on motivations for participating in two clinical trials of the same novel anti-plague vaccine, conducted in the United Kingdom (UK) and Uganda in 2021 and 2022.
methodsParticipants enrolled in PlaVac (UK) and PlaVac Uganda, Phase I trials of ChAdOx1 Plague vaccine, were invited to complete an optional questionnaire and semi-structured interview examining motivations for participating, including questions on the impact of the COVID-19 pandemic on their decision. Questionnaires were self-administered and interviewer-administered for UK and Uganda studies, respectively. Interviews were conducted in local languages, transcribed in English, and analysed using thematic analysis. Results were compared between studies.
resultsThirty-one of the 45 (68.9%; 25.8% female) UK trial participants and all 36 (100.0%; 27.8% female) of the Uganda trial participants completed questionnaires responses, and 19 Uganda questionnaire respondents completed interviews. Responses to questions on the impact of the COVID-19 pandemic on volunteering decisions were divergent between countries, with little effect for UK participants but a strong positive effect for Ugandan participants. Themes relating to this effect were "contributor, not cause" in the UK, and in Uganda were preparedness (wanting to contribute to vaccine development to prevent suffering and death from future epidemics), increased awareness (understanding the vaccine development process and seeing rapidly deployed COVID-19 vaccine trials gave them confidence), and personal protection (believing themselves to be protected by the novel plague vaccine). Participants in both studies expressed trust and confidence in the study vaccine which shares the same adenoviral-vectored platform technology used to elicit an immune response (ChAdOx1) with the COVID-19 vaccine ChAdOx1 nCoV-19 (Vaxzevria, AstraZeneca).
conclusionsFor Ugandan participants, COVID-19 and mass vaccination increased knowledge about vaccines and trials and encouraged them to participate in research, but had little impact on UK volunteers. There was no evidence of a negative effect of perceptions of the related ChAdOx1 nCoV-19 vaccine on trial participants' confidence in the novel plague vaccine's safety. TRIAL REGISTRATIONS: Current controlled trial: ISRCTN41077863, prospective registration date: 19/03/2021, and current controlled trial: ISRCTN79243381, prospective registration date 05/08/2022.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.